E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
Top Cited Papers
Open Access
- 5 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Chemistry
Abstract
Proteolysis-targeting chimeras (PROTACs) have received tremendous attention as a new and exciting class of therapeutic agents that promise to significantly impact drug discovery. These bifunctional molecules consist of a target binding unit, a linker, and an E3 ligase binding moiety. The chemically-induced formation of ternary complexes leads to ubiquitination and proteasomal degradation of target proteins. Among the plethora of E3 ligases, only a few have been utilized for the novel PROTAC technology. However, extensive knowledge on the preparation of E3 ligands and their utilization for PROTACs has already been acquired. This review provides an in-depth analysis of synthetic entries to functionalized ligands for the most relevant E3 ligase ligands, i.e. CRBN, VHL, IAP, and MDM2. Less commonly used E3 ligase and their ligands are also presented. We compare different preparative routes to E3 ligands with respect to feasibility and productivity. A particular focus was set on the chemistry of the linker attachment by discussing the synthetic opportunities to connect the E3 ligand at an appropriate exit vector with a linker to assemble the final PROTAC. This comprehensive review includes many facets involved in the synthesis of such complex molecules and is expected to serve as a compendium to support future synthetic attempts towards PROTACs.Keywords
This publication has 165 references indexed in Scilit:
- Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administrationCancer Chemotherapy and Pharmacology, 2012
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α InteractionJournal of the American Chemical Society, 2012
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomideBlood, 2011
- Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesisHuman Molecular Genetics, 2011
- Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target proteinFEBS Letters, 2011
- Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomicsBioorganic & Medicinal Chemistry Letters, 2008
- A Practical and Efficient Synthesis of Thalidomide via Na/Liquid NH3 Methodology1Organic Process Research & Development, 2005
- von Hippel–Lindau tumor suppressor: not only HIF's executionerTrends in Molecular Medicine, 2004
- Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted DegradationJournal of the American Chemical Society, 2004